Clinical Trials Logo

Filter by:
NCT ID: NCT04600895 Completed - Covid19 Clinical Trials

The Prevent Severe COVID-19 (PRESECO) Study

PRESECO
Start date: November 30, 2020
Phase: Phase 3
Study type: Interventional

Double-blinded, placebo control, randomized, phase-3 clinical trial to evaluate clinical efficacy of Favipiravir in patients with mild to moderate symptoms related to COVID-19 infection

NCT ID: NCT04600765 Completed - Inflammation Clinical Trials

hsCRP Clinical Inflammation Marker for Human Bisphenol A Food Contamination

Start date: November 25, 2019
Phase: N/A
Study type: Interventional

Dietary intervention studies thus far have failed to be replicable or causal.This is particularly relevant regarding plastic-derived chemicals (PDCs),This first-of-a-kind dietary intervention study explores a potential causal relationship between human serum levels of BPA and High-Sensitivity C-Reactive Protein (hsCRP)

NCT ID: NCT04600687 Completed - HIV Infections Clinical Trials

B/F/TAF Ease of Swallowability Trial

BEST
Start date: November 6, 2018
Phase: N/A
Study type: Interventional

The trial will assess the tolerability and swallowability of a STR placebo of B/F/TAF as compared to DTG/ABC/3TC placebo STR in healthy individuals and HIV antiretroviral naïve patients. The study team will evaluate the ease of swallow and patient's tolerance of the medication formulation, an important, yet often overlooked aspect of ART adherence, with the potential for significant impact on patient's outcomes.

NCT ID: NCT04600622 Completed - Diabetes Mellitus Clinical Trials

Adapting and Assessing the Feasibility of a Diabetes Self-management Telehealth Intervention

Start date: June 17, 2021
Phase: N/A
Study type: Interventional

The proposed project will use community based participatory research to adapt an existing diabetes self-management and education intervention with a telehealth intervention to be culturally relevant for rural English- and Spanish-speaking populations. Participants and care partners will receive a one-time, 5.5-hour telehealth intervention from a multidisciplinary team specializing in diabetes. The overarching aim of this study is to provide a sustainable model to provide diabetes specialty care to rural populations.

NCT ID: NCT04600557 Completed - Compassion Clinical Trials

A Compassion-based Intervention for Internal and External Shame

Start date: February 12, 2019
Phase: N/A
Study type: Interventional

This is a four-arm randomized pilot study aimed at reducing internal and/or external shame using self-compassion and/or compassion from others. The study is designed to test the theory that trait shame is comprised of both internal and external shame and to test compassion for others as an intervention for external shame.

NCT ID: NCT04600505 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Start date: October 19, 2020
Phase: Phase 1
Study type: Interventional

The study will evaluate bioavailability, pharmacokinetics, safety, and tolerability of budesonide, glycopyrronium and formoterol (BGF) metered dose inhaler (MDI) formulated with 3 different propellants: Propellant 1 (Treatment A [test]), Propellant 2 (Treatment B [test]) and Hydrofluoroalkane (HFA) (Treatment C [reference]).

NCT ID: NCT04600388 Completed - Menstrual Migraine Clinical Trials

Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine

Start date: September 9, 2020
Phase:
Study type: Observational

Post-marketing, retrospective, observational survey study. Users (menstruating women only) of Nerivio who have used Nerivio at least 4 times between October 2019 and December 2020 will be contacted by email and/or through an app notification and will be asked to complete a 5-minute online anonymous survey assessing satisfaction, effectiveness, and safety. Eligible users will sign an informed consent form (the consent language will appear as the first page of the survey, and participants will click either "agree" or "disagree" to the consent statement; those who click "agree" will proceed to the survey, those who click "disagree" will be brought to an exit page) and complete a survey asking about their satisfaction with Nerivio and the effectiveness and safety of the device for acute treatment of menstrual migraine. During the survey, participants will be screened to verify that they have menstrual migraine (self-reported) and have used Nerivio to treat menstrual migraines.

NCT ID: NCT04600375 Completed - Clinical trials for Hidradenitis Suppurativa

Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa

Start date: October 20, 2020
Phase: N/A
Study type: Interventional

This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.

NCT ID: NCT04600323 Completed - Clinical trials for Chronic Kidney Disease

Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD

Start date: February 1, 2021
Phase: Early Phase 1
Study type: Interventional

This is a pilot, randomized, double-blinded, placebo-controlled, 12-month trial of 50 patients with CKD stage 3b-4 with metabolic acidosis to examine the effect of sodium bicarbonate therapy on cognitive and cerebrovascular function.

NCT ID: NCT04600310 Completed - Clinical trials for Time Saved Performing Skin Antisepsis Process Outside the OR

ULTRAPREP Used to Perform Skin Antisepsis Outside the Operating Room

Start date: April 17, 2018
Phase: N/A
Study type: Interventional

Testing ULTRAPREP (consists of a clear bag sealed on one end with the other end enclosing the patients extremity) for safety and efficacy to perform skin antisepsis outside the operating room.